Michael Cooreman

1.2k total citations · 1 hit paper
23 papers, 910 citations indexed

About

Michael Cooreman is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, Michael Cooreman has authored 23 papers receiving a total of 910 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Epidemiology, 9 papers in Hepatology and 8 papers in Surgery. Recurrent topics in Michael Cooreman's work include Liver Disease Diagnosis and Treatment (9 papers), Hepatitis C virus research (8 papers) and Hepatitis B Virus Studies (6 papers). Michael Cooreman is often cited by papers focused on Liver Disease Diagnosis and Treatment (9 papers), Hepatitis C virus research (8 papers) and Hepatitis B Virus Studies (6 papers). Michael Cooreman collaborates with scholars based in United States, Netherlands and Germany. Michael Cooreman's co-authors include Wilma P. Paulij, Geert Leroux‐Roels, K. J. Hengels, Neil S. Ryder, Kai Lin, Sue Ma, Beat Weidmann, Choi-Lai Tiong-Yip, Carmen Langa and Calvin Vary and has published in prestigious journals such as Nature Communications, Blood and Gastroenterology.

In The Last Decade

Michael Cooreman

21 papers receiving 879 citations

Hit Papers

Pan-PPAR agonist lanifibranor improves insulin resistance... 2025 2026 2025 10 20 30
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Pan-PPAR agonist lanifibranor improves insulin resistance and hepatic steatosis in patients with T2D and MASLD
    2025 32 citations Diana Barb, Srilaxmi Kalavalapalli et al. Journal of Hepatology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Cooreman United States 13 417 364 254 115 82 23 910
Pascal Lapierre Canada 24 856 2.1× 1.0k 2.8× 325 1.3× 240 2.1× 246 3.0× 47 1.8k
Myoung-Kuk Jang South Korea 9 454 1.1× 245 0.7× 708 2.8× 118 1.0× 228 2.8× 14 1.2k
Michael Manns Germany 25 858 2.1× 1.1k 3.0× 175 0.7× 314 2.7× 164 2.0× 51 1.6k
W. Michael McDonnell United States 13 178 0.4× 99 0.3× 185 0.7× 167 1.5× 80 1.0× 34 731
Asem Elfert Egypt 17 409 1.0× 379 1.0× 144 0.6× 211 1.8× 32 0.4× 61 852
Allan J. Morris United Kingdom 20 228 0.5× 187 0.5× 491 1.9× 227 2.0× 54 0.7× 50 1.2k
Barbara Palazzetti Italy 13 225 0.5× 96 0.3× 201 0.8× 175 1.5× 379 4.6× 15 937
Shuji Kanmura Japan 18 278 0.7× 171 0.5× 218 0.9× 202 1.8× 164 2.0× 83 891
Toshio Morizane Japan 22 518 1.2× 509 1.4× 224 0.9× 324 2.8× 160 2.0× 82 1.3k
Anne‐Marie Durand‐Schneider France 16 200 0.5× 162 0.4× 313 1.2× 291 2.5× 47 0.6× 25 995

Countries citing papers authored by Michael Cooreman

Since Specialization
Citations

This map shows the geographic impact of Michael Cooreman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Cooreman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Cooreman more than expected).

Fields of papers citing papers by Michael Cooreman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Cooreman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Cooreman. The network helps show where Michael Cooreman may publish in the future.

Co-authorship network of co-authors of Michael Cooreman

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Cooreman. A scholar is included among the top collaborators of Michael Cooreman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Cooreman. Michael Cooreman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Barb, Diana, Srilaxmi Kalavalapalli, Eddison Godinez Leiva, et al.. (2025). Pan-PPAR agonist lanifibranor improves insulin resistance and hepatic steatosis in patients with T2D and MASLD. Journal of Hepatology. 82(6). 979–991. 32 indexed citations breakdown →
2.
Boursier, Jérôme, Marine Roux, Manal F. Abdelmalek, et al.. (2025). Biomarkers of Histological Response in Lanifibranor-treated Patients With Metabolic Dysfunction-associated Steatohepatitis. Clinical Gastroenterology and Hepatology. 23(13). 2499–2508.e8.
3.
Cooreman, Michael, Luisa Vonghia, & Sven Francque. (2024). MASLD/MASH and type 2 diabetes: Two sides of the same coin? From single PPAR to pan-PPAR agonists. Diabetes Research and Clinical Practice. 212. 111688–111688. 24 indexed citations
4.
Cooreman, Michael, Javed Butler, Robert P. Giugliano, et al.. (2024). The pan-PPAR agonist lanifibranor improves cardiometabolic health in patients with metabolic dysfunction-associated steatohepatitis. Nature Communications. 15(1). 3962–3962. 31 indexed citations
5.
Cooreman, Michael, Sven Francque, Philippe Huot-Marchand, et al.. (2023). Correlation between severity of hepatic steatosis and markers of cardiometabolic health, and effect of lanifibranor therapy in patients with non-cirrhotic NASH. Journal of Hepatology. 78. S823–S823.
6.
7.
Manns, Michael P., John M. Vierling, Bruce R. Bacon, et al.. (2014). The Combination of MK-5172, Peginterferon, and Ribavirin Is Effective in Treatment-Naive Patients With Hepatitis C Virus Genotype 1 Infection Without Cirrhosis. Gastroenterology. 147(2). 366–376.e6. 28 indexed citations
8.
9.
10.
Toombs, Christopher F., Michael A. Insko, Edward A. Wintner, et al.. (2010). Detection of exhaled hydrogen sulphide gas in healthy human volunteers during intravenous administration of sodium sulphide. British Journal of Clinical Pharmacology. 69(6). 626–636. 106 indexed citations
11.
Cooreman, Michael, et al.. (2008). 13C-Harnstoff-Atemtest als nicht-invasive Methode zum Nachweis von Helicobacter (Campylobacter) pylori. DMW - Deutsche Medizinische Wochenschrift. 115(10). 367–371. 1 indexed citations
12.
Ma, Sue, Choi-Lai Tiong-Yip, Beat Weidmann, et al.. (2006). NIM811, a Cyclophilin Inhibitor, Exhibits Potent In Vitro Activity against Hepatitis C Virus Alone or in Combination with Alpha Interferon. Antimicrobial Agents and Chemotherapy. 50(9). 2976–2982. 133 indexed citations
13.
Botella, Luisa M., Tilman Sánchez-Elsner, Francisco Sanz‐Rodríguez, et al.. (2002). Transcriptional activation of endoglin and transforming growth factor-β signaling components by cooperative interaction between Sp1 and KLF6: their potential role in the response to vascular injury. Blood. 100(12). 4001–4010. 153 indexed citations
14.
Cooreman, Michael, Geert Leroux‐Roels, & Wilma P. Paulij. (2001). Vaccine- and hepatitis B immune globulin-induced escape mutations of hepatitis B virus surface antigen. Journal of Biomedical Science. 8(3). 237–247. 161 indexed citations
15.
Cooreman, Michael, et al.. (2001). Polyclonal anti-HBs antibodies of adult vaccinees bind to G145R and other naturally occurring mutant HBsAg. Gastroenterology. 120(5). A384–A385. 1 indexed citations
16.
Cooreman, Michael, Geert Leroux‐Roels, & Wilma P. Paulij. (2001). Vaccine- and Hepatitis B Immune Globulin-Induced Escape Mutations of Hepatitis B Virus Surface Antigen. Journal of Biomedical Science. 8(3). 237–247. 12 indexed citations
17.
Cooreman, Michael, et al.. (1997). A 58-year-old man with sarcoidosis complicated by focal crescentic glomerulonephritis. Nephrology Dialysis Transplantation. 12(12). 2703–2707. 9 indexed citations
18.
Cooreman, Michael, et al.. (1996). Hepatitis C Virus: Biological and Clinical Consequences of Genetic Heterogeneity. Scandinavian Journal of Gastroenterology. 31(sup218). 106–115. 24 indexed citations
19.
Tomasi, Jean‐Paul, G. Bigaignon, Michel Delmée, et al.. (1990). Comparison Of Anti-Helicobacter (Campylobacter) PyloriIGG Antibodies Between Different Areas of Belgium. Acta Clinica Belgica. 45(4). 240–246. 1 indexed citations
20.
Cooreman, Michael, et al.. (1988). Exsudative enteropathie beim klippel-trenaunay-syndrom. Journal of Molecular Medicine. 66(11). 502–507. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pascal Lapierre Breakdown of academic impact, for papers by Myoung-Kuk Jang Breakdown of academic impact, for papers by Michael Manns Breakdown of academic impact, for papers by W. Michael McDonnell Breakdown of academic impact, for papers by Asem Elfert Breakdown of academic impact, for papers by Allan J. Morris Breakdown of academic impact, for papers by Barbara Palazzetti Breakdown of academic impact, for papers by Shuji Kanmura Breakdown of academic impact, for papers by Toshio Morizane Breakdown of academic impact, for papers by Anne‐Marie Durand‐Schneider
Rankless by CCL
2026